↓ Skip to main content

Fibroblast growth factor 23 contributes to diminished bone mineral density in childhood inflammatory bowel disease

Overview of attention for article published in BMC Gastroenterology, May 2012
Altmetric Badge

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
57 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Fibroblast growth factor 23 contributes to diminished bone mineral density in childhood inflammatory bowel disease
Published in
BMC Gastroenterology, May 2012
DOI 10.1186/1471-230x-12-44
Pubmed ID
Authors

Mostafa Abdel-Aziz El-Hodhod, Ahmad Mohamed Hamdy, Amal Ahmed Abbas, Sherine George Moftah, Alhag Ahmed Mohamed Ramadan

Abstract

Diminished bone mineral density (BMD) is of significant concern in pediatric inflammatory bowel disease (IBD). Exact etiology is debatable. The recognition of fibroblast growth factor 23 (FGF23), a phosphaturic hormone related to tumor necrosis factor alpha (TNF-α) makes it plausible to hypothesize its possible relation to this pathology.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
India 1 2%
Unknown 55 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 12%
Researcher 6 11%
Student > Doctoral Student 6 11%
Student > Ph. D. Student 6 11%
Student > Postgraduate 5 9%
Other 9 16%
Unknown 18 32%
Readers by discipline Count As %
Medicine and Dentistry 23 40%
Nursing and Health Professions 4 7%
Agricultural and Biological Sciences 2 4%
Computer Science 2 4%
Biochemistry, Genetics and Molecular Biology 1 2%
Other 3 5%
Unknown 22 39%